ABcann Global Corp. (ABCN.V)

Future? Produces plant-based medicine. They’re smart, likes the management team because of their pharma experience. Oversupply still to get through, but if you’re willing to look beyond the next year, stick with it. If you’re worried about storm clouds, put your money into a high-yielding energy stock, or another commodity, and then come back in later in 2019.

He thinks the smaller and intermediate producers are going to have a tough time making money in weed as the big 4 continue to lower costs and raise capital at lower costs.

It does look interesting. They have an expansion plan. He thinks the caller might be onto something. He would not run out and buy it because the valuation is still $150 Million.